{"doi":"10.1021/acschembio.2c00378","title":"Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses","abstract":"Inhibition of the protein kinase CSNK2 with any of 30 specific and selective inhibitors representing different chemotypes, blocked replication of pathogenic human, bat, and murine β-coronaviruses. The potency of in-cell CSNK2A target engagement across the set of inhibitors correlated with antiviral activity and genetic knockdown confirmed the essential role of the CSNK2 holoenzyme in β-coronavirus replication. Spike protein endocytosis was blocked by CSNK2A inhibition, indicating that antiviral activity was due in part to a suppression of viral entry. CSNK2A inhibition may be a viable target for the development of anti-SARS-like β-coronavirus drugs.","journal":"ACS Chemical Biology","year":2022,"id":249963,"datarank":0.5050943744979712,"base_score":3.367295829986474,"endowment":3.367295829986474,"self_citation_contribution":0.5050943744979712,"citation_network_contribution":0.0,"self_endowment_contribution":0.5050943744979712,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":28,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9548,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":891300,"name":"Rebekah J. Dickmander","orcid":"0000-0002-5367-6587","position":1,"is_corresponding":false},{"id":891301,"name":"Armin Bayati","orcid":"0000-0002-5960-0479","position":2,"is_corresponding":false},{"id":333823,"name":"Sharon Taft-Benz","orcid":"0000-0002-0965-8760","position":3,"is_corresponding":false},{"id":891302,"name":"Jeffery L. Smith","orcid":"0000-0003-2189-0420","position":4,"is_corresponding":false},{"id":273786,"name":"Carrow I. Wells","orcid":"0000-0003-4799-6792","position":5,"is_corresponding":false},{"id":333821,"name":"Emily A. Madden","orcid":"0000-0003-0209-914X","position":6,"is_corresponding":false},{"id":280749,"name":"Joshua B. Brown","orcid":"0000-0002-6936-035X","position":7,"is_corresponding":false},{"id":547387,"name":"Erik M. Lenarcic","orcid":null,"position":8,"is_corresponding":false},{"id":105503,"name":"Boyd L. Yount","orcid":"0000-0002-6099-8429","position":9,"is_corresponding":false},{"id":891303,"name":"Edcon Chang","orcid":"0000-0001-9534-0291","position":10,"is_corresponding":false},{"id":376426,"name":"Alison D. Axtman","orcid":"0000-0003-4779-9932","position":11,"is_corresponding":false},{"id":5952,"name":"Ralph S. Baric","orcid":"0000-0001-6827-8701","position":12,"is_corresponding":false},{"id":275061,"name":"Mark T. Heise","orcid":"0000-0001-5829-8477","position":13,"is_corresponding":false},{"id":729703,"name":"Peter S. McPherson","orcid":"0000-0001-7806-5662","position":14,"is_corresponding":false},{"id":392102,"name":"Nathaniel J. Moorman","orcid":"0000-0003-4952-6858","position":15,"is_corresponding":false},{"id":273796,"name":"Timothy M. Willson","orcid":"0000-0003-4181-8223","position":16,"is_corresponding":false},{"id":694934,"name":"Xuan Yang","orcid":"0000-0001-6818-158X","position":0,"is_corresponding":true}],"reference_count":64,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-07-19T00:24:28.242323Z","pmid":"35723434","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}